Open Access

ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway

  • Authors:
    • Changpeng Hu
    • Huyue Zhou
    • Yali Liu
    • Jingbin Huang
    • Wuyi Liu
    • Qian Zhang
    • Qin Tang
    • Fangfang Sheng
    • Guobing Li
    • Rong Zhang
  • View Affiliations

  • Published online on: August 30, 2019     https://doi.org/10.3892/ijo.2019.4864
  • Pages: 833-844
  • Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Rho‑associated protein kinase 1 (ROCK1), a member of the ROCK family, serves an important function in cell migration and invasion in neoplasms. ROCK1 has been found to be overexpressed in several types of cancers. However, the role of ROCK1 in non‑small‑cell lung cancer (NSCLC) is poorly understood. In the present study, ROCK1 was found to be overexpressed in NSCLC cells and tissues, and it was associated with poor survival of NSCLC patients. Subsequently, ROCK1 knockdown NSCLC cell lines were established using shRNA. ROCK1 knockdown significantly reduced the migration and invasion ability in the cell monolayer scratching and Transwell assays. ROCK1 knockdown was also found to markedly inhibit cell adhesion ability. Moreover, the phosphorylation of focal adhesion kinase (FAK) was inhibited by ROCK1 knockdown, reducing NSCLC cell migration and invasion ability. This mechanistic study revealed that ROCK1 significantly enhanced cell migration and invasion by inhibiting the phosphatase and tensin homolog (PTEN)/phosphoinositide 3‑kinase (PI3K)/FAK pathway. More importantly, the interruption of the PTEN/PI3K/FAK pathway markedly rescued the inhibition of cell migration and invasion mediated by ROCK1 knockdown. Taken together, these results suggest a novel role for ROCK1 in cell migration and invasion by inhibiting cell adhesion ability, and indicate that ROCK1 may be of value as a therapeutic target for the treatment of NSCLC.

References

1 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI

3 

She K, Yan H, Huang J, Zhou H and He J: miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer. Cell Prolif:. 51:2018. View Article : Google Scholar

4 

Yang J, Zhao H, Xin Y and Fan L: MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. J Cell Biochem. 115:987–995. 2014. View Article : Google Scholar

5 

Kohler J: Second-line treatment of NSCLC-the Pan-ErbB inhibitor afatinib in times of shifting paradigms. Front Med (Lausanne). 4:92017.

6 

Patel RA, Liu Y, Wang B, Li R and Sebti SM: Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities. Oncogene. 33:550–555. 2014. View Article : Google Scholar :

7 

Vigil D, Kim TY, Plachco A, Garton AJ, Castaldo L, Pachter JA, Dong H, Chen X, Tokar B, Campbell SL and Der CJ: ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res. 72:5338–5347. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Rath N and Olson MF: Rho-associated kinases in tumorigenesis: Re-considering ROCK inhibition for cancer therapy. EMBO Rep. 13:900–908. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Xu S, Guo X, Gao X, Xue H, Zhang J, Guo X, Qiu W, Zhang P and Li G: Macrophage migration inhibitory factor enhances autophagy by regulating ROCK1 activity and contributes to the escape of dendritic cell surveillance in glioblastoma. Int J Oncol. 49:2105–2115. 2016. View Article : Google Scholar : PubMed/NCBI

10 

Huang GX, Wang Y, Su J, Zhou P, Li B, Yin LJ and Lu J: Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma. Cancer Lett. 410:1–11. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Wang Z, Wang Z, Liu J and Yang H: Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1. Biomed Pharmacother. 107:598–605. 2018. View Article : Google Scholar : PubMed/NCBI

12 

Zhan Y, Zheng N, Teng F, Bao L, Liu F, Zhang M, Guo M, Guo W, Ding G and Wang Q: MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1. Oncotarget. 8:67169–67180. 2017. View Article : Google Scholar : PubMed/NCBI

13 

Croft DR, Sahai E, Mavria G, Li S, Tsai J, Lee WM, Marshall CJ and Olson MF: Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res. 64:8994–9001. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Peng Y, Chen Z, Chen Y, Li S, Jiang Y, Yang H, Wu C, You F, Zheng C, Zhu J, et al: ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness. Acta Biomater. 88:86–101. 2019. View Article : Google Scholar : PubMed/NCBI

15 

Zhao J and Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Liu W, Liang Y, Chan Q, Jiang L and Dong J: CX3CL1 promotes lung cancer cell migration and invasion via the Src/focal adhesion kinase signaling pathway. Oncol Rep. 41:1911–1917. 2019.PubMed/NCBI

17 

Gates RE, King LE Jr, Hanks SK and Nanney LB: Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ. 5:891–899. 1994.PubMed/NCBI

18 

Azab AK, Azab F, Blotta S, Pitsillides CM, Thompson B, Runnels JM, Roccaro AM, Ngo HT, Melhem MR, Sacco A, et al: RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemo-taxis in multiple myeloma. Blood. 114:619–629. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Jaraiz-Rodriguez M, Tabernero MD, Gonzalez-Tablas M, Otero A, Orfao A, Medina JM and Tabernero A: A short region of Connexin43 reduces human glioma stem cell migration, invasion, and survival through Src, PTEN, and FAK. Stem Cell Reports. 9:451–463. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Zhang LL, Liu J, Lei S, Zhang J, Zhou W and Yu HG: PTEN inhibits the invasion and metastasis of gastric cancer via down-regulation of FAK expression. Cell Signal. 26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Tamura M, Gu J, Matsumoto K, Aota S, Parsons R and Yamada KM: Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 280:1614–1617. 1998. View Article : Google Scholar : PubMed/NCBI

22 

Julian L and Olson MF: Rho-associated coiled-coil containing kinases (ROCK): Structure, regulation, and functions. Small GTPases. 5:e298462014. View Article : Google Scholar : PubMed/NCBI

23 

Guan R, Xu X, Chen M, Hu H, Ge H, Wen S, Zhou S and Pi R: Advances in the studies of roles of Rho/Rhokinase in diseases and the development of its inhibitors. Eur J Med Chem. 70:613–622. 2013. View Article : Google Scholar

24 

Fragoso R and Barata JT: Kinases, tails and more: Regulation of PTEN function by phosphorylation. Methods. 77-78:75–81. 2015. View Article : Google Scholar

25 

Malemud CJ: The PI3K/Akt/PTEN/mTOR pathway: A fruitful target for inducing cell death in rheumatoid arthritis? Future Med Chem. 7:1137–1147. 2015. View Article : Google Scholar : PubMed/NCBI

26 

Zhang R, Li G, Zhang Q, Tang Q, Huang J, Hu C, Liu Y, Wang Q, Liu W, Gao N and Zhou S: Hirsutine induces mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3β pathway in human lung cancer cells. Cell Death Dis. 9:5982018. View Article : Google Scholar

27 

Rami-Porta R, Asamura H, Travis WD and Rusch VW: Lung cancer-major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 67:138–155. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohisto-chemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 8:138–140. 1987.In German. PubMed/NCBI

29 

Shi H, Chen S, Jin H, Xu C, Dong G, Zhao Q, Wang W, Zhang H, Lin W, Zhang J, et al: Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci. 100:1585–1590. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Wang GH, Yao L, Xu HW, Tang WT, Fu JH, Hu XF, Cui L and Xu XM: Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncol Lett. 5:544–548. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Toro-Tapia G, Villaseca S, Beyer A, Roycroft A, Marcellini S, Mayor R and Torrejón M: The Ric-8A/Ga13/FAK signaling cascade controls focal adhesion formation during neural crest cell migration in Xenopus. Development. 145:pii: dev164269. 2018. View Article : Google Scholar

32 

Liu C, Li Y, Xing Y, Cao B, Yang F, Yang T, Ai Z, Wei Y and Jiang J: The interaction between cancer stem cell marker CD133 and Src protein promotes focal adhesion kinase (FAK) phosphor-ylation and cell migration. J Biol Chem. 291:15540–15550. 2016. View Article : Google Scholar : PubMed/NCBI

33 

Matsuda S, Kawamoto K, Miyamoto K, Tsuji A and Yuasa K: PCTK3/CDK18 regulates cell migration and adhesion by negatively modulating FAK activity. Sci Rep. 7:455452017. View Article : Google Scholar : PubMed/NCBI

34 

Zhang J, Li L, Peng Y, Chen Y, Lv X, Li S, Qin X, Yang H, Wu C and Liu Y: Surface chemistry induces mitochondria-mediated apoptosis of breast cancer cells via PTEN/PI3K/AKT signaling pathway. Biochim Biophys Acta Mol Cell Res. 1865:172–185. 2018. View Article : Google Scholar

35 

Alfieri R, Giovannetti E, Bonelli M and Cavazzoni A: New treatment opportunities in phosphatase and tensin homolog (PTEN)-deficient tumors: Focus on PTEN/Focal adhesion kinase pathway. Front Oncol. 7:1702017. View Article : Google Scholar : PubMed/NCBI

36 

Vemula S, Shi J, Hanneman P, Wei L and Kapur R: ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Blood. 115:1785–1796. 2010. View Article : Google Scholar :

37 

Li GB, Cheng Q, Liu L, Zhou T, Shan CY, Hu XY, Zhou J, Liu EH, Li P and Gao N: Mitochondrial translocation of cofilin is required for allyl isothiocyanate-mediated cell death via ROCK1/PTEN/PI3K signaling pathway. Cell Commun Signal. 11:502013. View Article : Google Scholar : PubMed/NCBI

38 

André E and Becker-André M: Expression of an N-terminally truncated form of human focal adhesion kinase in brain. Biochem Biophys Res Commun. 190:140–147. 1993. View Article : Google Scholar : PubMed/NCBI

39 

Zhang J and Hochwald SN: The role of FAK in tumor metabolism and therapy. Pharmacol Ther. 142:154–163. 2014. View Article : Google Scholar

40 

Schaller MD: Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta. 1540:1–21. 2001. View Article : Google Scholar : PubMed/NCBI

41 

Siesser PM and Hanks SK: The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res. 12:3233–3237. 2006. View Article : Google Scholar : PubMed/NCBI

42 

Ucar DA and Hochwald SN: FAK and interacting proteins as therapeutic targets in pancreatic cancer. Anticancer Agents Med Chem. 10:742–746. 2010. View Article : Google Scholar

43 

Sulzmaier FJ, Jean C and Schlaepfer DD: FAK in cancer: Mechanistic findings and clinical applications. Nat Rev Cancer. 14:598–610. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Roycroft A, Szabó A, Bahm I, Daly L, Charras G, Parsons M and Mayor R: Redistribution of adhesive forces through Src/FAK drives contact inhibition of locomotion in neural crest. Dev Cell. 45:565–579.e3. 2018. View Article : Google Scholar : PubMed/NCBI

45 

Gilkes DM, Xiang L, Lee SJ, Chaturvedi P, Hubbi ME, Wirtz D and Semenza GL: Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells. Proc Natl Acad Sci USA. 111:E384–E393. 2014. View Article : Google Scholar

46 

Amin E, Dubey BN, Zhang SC, Gremer L, Dvorsky R, Moll JM, Taha MS, Nagel-Steger L, Piekorz RP, Somlyo AV and Ahmadian MR: Rho-kinase: Regulation, (dys)function, and inhibition. Biol Chem. 394:1399–1410. 2013. View Article : Google Scholar : PubMed/NCBI

47 

Wermke M, Camgoz A, Paszkowski-Rogacz M, Thieme S, von Bonin M, Dahl A, Platzbecker U, Theis M, Ehninger G, Brenner S, et al: RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug. Blood. 125:3760–3768. 2015. View Article : Google Scholar : PubMed/NCBI

48 

Zhu L, Wang X, Wang T, Zhu W and Zhou X: miR-494-3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway. Mol Med Rep. 19:581–588. 2019.

49 

Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL: MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI

50 

Fu Q, Huang Y, Ge C, Li Z, Tian H, Li Q, Li H, Li R, Tao X, Xue Y, et al: SHIP1 inhibits cell growth, migration, and invasion in nonsmall cell lung cancer through the PI3K/AKT pathway. Oncol Rep. 41:2337–2350. 2019.PubMed/NCBI

51 

Jiang W, Cheng Y, Zhao N, Li L, Shi Y, Zong A and Wang F: Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells. Int J Biol Macromol. 107:349–362. 2018. View Article : Google Scholar

Related Articles

Journal Cover

October 2019
Volume 55 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Hu, C., Zhou, H., Liu, Y., Huang, J., Liu, W., Zhang, Q. ... Zhang, R. (2019). ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway. International Journal of Oncology, 55, 833-844. https://doi.org/10.3892/ijo.2019.4864
MLA
Hu, C., Zhou, H., Liu, Y., Huang, J., Liu, W., Zhang, Q., Tang, Q., Sheng, F., Li, G., Zhang, R."ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway". International Journal of Oncology 55.4 (2019): 833-844.
Chicago
Hu, C., Zhou, H., Liu, Y., Huang, J., Liu, W., Zhang, Q., Tang, Q., Sheng, F., Li, G., Zhang, R."ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway". International Journal of Oncology 55, no. 4 (2019): 833-844. https://doi.org/10.3892/ijo.2019.4864